Abstract
Recombinant Sendai-virus (SeV) vector transduces airway epithelium efficiently via the apical membrane and leads to high, but transient gene expression. The treatment of chronic diseases may require repeated administration of the virus. We have previously shown that three repeat administrations of recombinant Sendai virus (DF/SeV) did not lead to measurable luciferase (lux) expression after the third administration. However, as part of these experiments we noted that even after one administration, lux expression was lower than expected for a given virus dose.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have